I can't say for sure. Depends on how many patients the FDA wants for the P3 (my guess is its well more than the 150 the AVXL message board has repeated claimed based on an inability to read yesterday's PR correctly) and then what steps after that depending on how convincing the results are from the P3 (such as an additional P3 if results are so-so) scheduled to enroll later this year. I would sell a million or two to be sure but may not be the end of the world if they don't.
News 
Market Data 
Discover 
